Moving from sidelines to lean bullish, and the reason is that the print replaced the valuation framework: the trailing multiple fell from 49.6x to 17.3x, Q1 FY27 guidance calls for another 15% revenue step with margins held at 83–85%, and a $14B buyback was added. I refused to take a direction ahead of the print on the grounds that meeting expectations would be sell-the-news — instead it massively beat and was sold anyway, because what's being sold is a NAND price forecast rather than this company's operations. Enter at $1,180–1,250 on a pullback within this week's range, stop at $1,090 structurally above the $1,015.89 low from 7/29, and target $1,520 short of the 50-day at $1,695.65. The risk is explicit: if NAND spot keeps falling fast, management's margin guidance is invalidated and $1,090 is where I admit it.
WTTRSelect Water Solutions, Inc.CloseLong→Neutral$20.7-7.01%
Down 7.01% in a sharp give-back; RSI is 57.0 but a 77.4x multiple against EPS down 17.0% and revenue down 2.0% cannot support the valuation. Closing the position.
Down 1.29% through the structural support near the 50-day at $99.00 with RSI(7) weakening to 41.2, and it sits in the same aerospace supply chain as HONA and BA where the casting-shortage spillover isn't priced. Closing the position until that variable clears.
Up 0.77% but still 36% below the 50-day at HK$184.85 after a 27.2% month, with RSI weak at 41.4. The fiber demand narrative diverges sharply from the price and only eight analysts cover it. Closing the position pending trend confirmation.
Up 0.69% but still down 51.7% on the month and 41% below the 50-day at HK$60.02, with RSI weak at 37.6. The laminate cycle hasn't bottomed and yesterday's entry rationale is too thin. Closing the position.
-31.04%07-22“Revenue up nearly fivefold, an 84.6% gross margin, next quarter guided 15% higher — and the stock still fell 6.81%. The print crushed the multiple to 17.3x: the market is convicting it in advance for a price cycle that hasn't happened”
Technicals — It closed at $1,258.58, down 6.81%, yet the week is still up 10.9% — the earlier run absorbed part of the earnings expectation, making this a sell-the-news reaction rather than a collapse. Price holds above the 20-day but sits 25.8% below the 50-day ($1,695.65) and far above the 200-day ($866.93). RSI(14) at 43.1 and RSI(7) at 43.0 are both neutral-to-soft with no overbought pressure. ATR of $188.27 implies a 15.0% daily range, still the most extreme on the board. The stock is 46.5% below its June high of $2,354.39 and down 22.3% on the month.
Fundamentals — FY26 Q4 revenue reached $8.965B, up 51% sequentially and 372% year over year, with GAAP net income of $6.90B and diluted EPS of $43.97, non-GAAP EPS of $39.25 and an 84.6% gross margin — all above the top end of guidance. Full-year revenue of $20.25B grew 175%. Roughly one third of the sequential gain came from volume and two thirds from pricing. Q1 FY27 guidance calls for revenue of $10.3–10.8B, a non-GAAP gross margin of 83–85% and EPS of $44–46, alongside a new $14B buyback authorization. The pivotal change: the trailing multiple fell from 49.6x pre-print to 17.3x — driven not by the share price but by an explosion in the earnings denominator.
News — SanDisk released FY26 Q4 results after the close on 8/5, beating the high end of guidance on every metric. Yet the stock fell 6.81% on 8/6 — not because of the print but because of what Western Digital said the same day: NAND spot pricing has turned down sharply, raising concerns about memory makers' gross margins. WDC plunged 13.03% and dragged the whole chain with it. The market's logic is plain: two thirds of SanDisk's 84.6% margin came from pricing, so if NAND has peaked, that margin is a cycle-top reading rather than a run rate. Management's Q1 FY27 guidance of an 83–85% gross margin explicitly disputes that reading.
Short-term · 1–3 weeks
LongLean bullish
Moving from sidelines to lean bullish, and the reason is that the print replaced the valuation framework: the trailing multiple fell from 49.6x to 17.3x, Q1 FY27 guidance calls for another 15% revenue step with margins held at 83–85%, and a $14B buyback was added. I refused to take a direction ahead of the print on the grounds that meeting expectations would be sell-the-news — instead it massively beat and was sold anyway, because what's being sold is a NAND price forecast rather than this company's operations. Enter at $1,180–1,250 on a pullback within this week's range, stop at $1,090 structurally above the $1,015.89 low from 7/29, and target $1,520 short of the 50-day at $1,695.65. The risk is explicit: if NAND spot keeps falling fast, management's margin guidance is invalidated and $1,090 is where I admit it.
Entry $1180~1250Stop $1090Target $1520
Long-term · months+
Accumulate
A 17.3x multiple against 175% full-year revenue growth and an 84.6% gross margin, plus a $14B buyback and multiyear customer agreements, says this is not a one-quarter accident. AI enterprise SSD demand and the High Bandwidth Flash standard give NAND a path from storage medium to compute architecture.
Falling NAND spot pricing puts at risk the two thirds of margin that came from price
A 15.0% daily range demands extremely strict position sizing
A low multiple at peak cyclical earnings has historically been a trap
Signal BacktestCumulative -31.04%price itself -27.88%0/1 closed trades wonprofitable since 07-24
07-22Long$1,589.4 → closed $1,096.107-29-31.04%
08-07Long$1,258.58 → open → $1,258.58+0.00%
Community Voices
WSB · Mentions collapsed from 1,019 to 286, seven tenths gone in a day. Packed on earnings night, deserted the morning after. Whoever stayed is looking at 17.3x earnings, not a crowdOriginal ↗
Institutional Views
华尔街共识 · 30 analysts average a $2,274.74 target, roughly 80.7% above spot, at a 1.33 rating leaning strong buy — trimmed from $2,363.65 yesterday but still among the widest gaps on the board
-27.69%07-07“One line about NAND from WDC dragged the whole chain down, and Micron gave back just 1.31% while holding an 11.1% week. Same boat, and the market can still tell who eats off DRAM. The position opened two days ago survived its first interrogation”
Score8/10RSI(14) 47.91-week gain +11.1%P/E TTM 20.0Gross margin 72.6%Consensus upside +76.4%
Technicals — It closed at $881.47, down just 1.31% on a day the memory chain was gutted — WDC fell 13.03% and SNDK 6.81% — and that relative strength is the most notable data point today. Price remains 9.3% below the 50-day ($971.96) and far above the 200-day ($531.67). RSI(14) at 47.9 and RSI(7) at 50.1 are both neutral. The 11.1% weekly gain is intact and the monthly decline narrowed from -14.3% to -4.5%. ATR of $84.95 implies a 9.6% daily range. The intraday span of $827.00–$905.80 was violent but the close landed in the upper half. The $800 level remains the structural line beneath my stop reference.
Fundamentals — Trailing revenue of roughly $41.46B grew 167% with EPS up 697% on a 72.6% gross margin — elite for a memory supplier — at 20.0x earnings. The key distinction from SanDisk is business mix: Micron's profit engine is DRAM and HBM, whereas today's panic concerns NAND spot pricing. Bank of America's framing is worth recording: its base case already assumes Micron's DRAM prices fall 10% and NAND 18% in calendar 2028, and even under a severe bear case it believes Micron sustains strong profitability relative to prior cycles.
News — Micron swung through a wide $827.00–$905.80 range on 8/6 before closing down 1.31%. The whole semiconductor and memory complex was under pressure: Western Digital collapsed 13.03% on a sudden drop in NAND spot pricing and elevated inventory ahead of its planned separation, while SanDisk fell 6.81% despite a large beat. The central debate has shifted from whether AI demand is real to whether hyperscalers will earn attractive returns on their enormous AI investments, and after a huge first half for memory stocks many investors are locking in gains. Bank of America reiterated its bullish stance, arguing Micron's profitability far exceeds prior cycles even under a severe pricing decline.
Short-term · 1–3 weeks
LongLean bullish
Maintaining the long. Today was this position's first stress test and it passed: with the chain gutted — WDC -13.03%, SNDK -6.81% — Micron gave back only 1.31% and kept an 11.1% week intact. Business mix is the reason: today's panic originated in NAND spot pricing while Micron's profit engine is DRAM and HBM. The stop stays at $798 below the $800 level, a break of which invalidates the whole reversal; the entry zone shifts slightly from $855–885 to $845–880 and the target holds at $1,000. BofA's base case already embeds 2028 price declines, which buys this position time.
Entry $845~880Stop $798Target $1000
Long-term · months+
Accumulate
A 20.0x multiple against a 72.6% gross margin and 167% revenue growth, with structural HBM and DRAM demand driven directly by AI compute. BofA's bear-case math shows that even if a pricing downcycle arrives, the earnings base sits far above prior cycle troughs.
If falling NAND spot pricing spreads to DRAM, the valuation framework gets rewritten
There is still no data on the timing or scale of CXMT's ramp
Doubts over hyperscaler returns on AI capex weigh on the entire sector's multiple
Signal BacktestCumulative -27.69%price itself -14.61%0/2 closed trades wonprofitable since 07-10
07-07Long$984.75 → closed $853.207-17-13.36%
07-22Long$970.82 → closed $820.5307-29-15.48%
08-05Long$892.67 → open → $881.47-1.25%
Community Voices
WSB · Mentions fell from 357 to 223 for fifth place, with the crowd cooling while price gave up only 1.31%. WSB left, the price didn't — that divergence usually means the shares changed hands from retail to somebody elseOriginal ↗
Institutional Views
华尔街共识 · 56 analysts average a $1,554.51 target, roughly 76.4% above spot, at a 1.15 rating near strong buy
Bank of America · Reiterated its bullish view; the base case already assumes 10% DRAM and 18% NAND price declines in 2028, and even a severe bear case leaves earnings far above prior cyclesSource ↗
Neutral
6
WDCWestern Digital Corporation · Computer Peripherals
MomentumSocial Buzz
New today“Beat on both revenue and earnings and still lost 13% in a day — felled not by its own results but by its own words on NAND spot pricing. High inventory ahead of a separation is the last thing you want mentioned right now”
Technicals — It closed at $451.52, down 13.03%, with relative volume of 2.02x confirming panic selling. Price sliced 19.8% below the 50-day ($563.12) while holding 32.9% above the 200-day ($339.64). RSI(14) at 40.1 and RSI(7) at 33.6 have weakened without reaching oversold, meaning there is technically room to fall further. The stock is down 11.8% on the week and 15.2% on the month, with an ATR of $55.75 implying a 12.3% daily range, and sits 43.6% below its $799.87 high. There is no clear technical support beneath; the nearest structural level is the $400 round number.
Fundamentals — The quarter delivered EPS of $3.56 on $3.75B of revenue, beating on both lines, with trailing net income up 371.3% at a multiple of just 18.7x. But trailing revenue is down 2.7%, which exposes the problem: the earnings surge came from pricing rather than volume. Three pressures compound — a sudden drop in NAND spot pricing threatening gross margin, intensifying competition, and high inventory ahead of the planned business separation. The company beat and cut guidance in the same breath, the combination markets tolerate least.
News — Western Digital's 13.03% plunge on 8/6 was the epicenter of the day's memory selloff. The company beat on both sales and earnings yet cut guidance, and the reason it gave was industry-wide: a sudden downturn in NAND spot pricing, compounded by intensifying competition and elevated inventory ahead of the business separation, all threatening gross margin. The damage far exceeded the company itself — it dragged SanDisk (-6.81%) and Micron (-1.31%) down the same day, even though SanDisk had just posted 372% revenue growth at an 84.6% gross margin. Today's pricing logic across the entire memory chain was rewritten by that single line from Western Digital.
Short-term · 1–3 weeks
NeutralSidelines
No direction here. WDC must be separated from SNDK and MU: SanDisk and Micron were dragged down by someone else's news, while Western Digital supplied its own reason to cut. Trailing revenue down 2.7% shows its earnings surge came entirely from pricing — precisely what is now in question — making it the most levered of the three to this cycle. RSI(14) at 40.1 is not yet oversold, so there is technical room below, and the 48.7% consensus upside is stale data from before the cut. High inventory ahead of the separation is a variable with a timeline but no price. Wait for evidence NAND spot has stabilized.
Entry Sidelines; wait for evidence NAND spot pricing has stabilizedStop —Target —
Long-term · months+
Neutral
A 18.7x multiple against 371.3% earnings growth looks cheap, but trailing revenue down 2.7% shows the earnings rest entirely on price. The separation may unlock value, but only after the inventory and pricing variables settle.
Falling NAND spot pricing hits gross margin directly, as the company itself confirmed
High inventory ahead of the separation becomes a liability in a falling-price cycle
WSB · Mentions fell from 165 to 71: down 13% and nobody showed up to buy the dip. Retail read it correctly — when a company itself says inventory is high and prices are falling, that isn't a mispricingOriginal ↗
Institutional Views
华尔街共识 · 30 analysts average a $671.57 target, about 48.7% above spot, at a 1.35 buy rating — but these predate the guidance cut and a reset is unavoidable
+7.56%07-04“The semiconductor complex got dragged around by memory and it barely flinched, down 0.1% with a 13.2% week fully intact. While the street argues about returns on AI capex, the one selling the shovels never joins the debate”
Score8/10RSI(14) 61.41-week gain +13.2%P/E TTM 33.5Gross margin 74.1%Consensus upside +43.5%
Technicals — It closed at $218.99, down 0.10%, essentially unmoved on a day the memory chain was gutted and semis broadly struggled — among the strongest relative showings today. Price sits well above the 50-day ($205.85) and 200-day ($193.77) in a complete bullish stack. RSI(14) at 61.4 is healthily firm with RSI(7) at 71.2 warm but manageable. Weekly and monthly gains of 13.2% and 13.8% leave it just 7.4% below the $236.54 high. ATR of $7.79 implies a 3.6% daily range, among the mildest of today's deep dives — a number that by itself explains the difference in holding experience.
Fundamentals — Trailing revenue grew 70.7% and EPS 110.3% on a 74.1% gross margin at 33.5x earnings — an unusually good growth-to-valuation match at a $5.3T market capitalization. Sixty-four analysts carry a 1.12 rating near strong buy with an average target of $314.29 implying 43.5% upside, the most unified bullish consensus among megacap tech. The market's emerging doubt about hyperscaler returns on AI capex is in theory Nvidia's largest long-term risk, yet in the near term it remains the direct recipient of that spending.
News — Nvidia finished essentially flat on 8/6, down 0.10%, showing marked resilience amid a broad tech and semiconductor selloff. Two pressures drove the sector: the NAND pricing panic triggered by Western Digital that dragged the memory chain, and a newly concentrated doubt over whether hyperscalers can earn attractive returns on their enormous AI investments — the first systematic challenge to the entire AI capex narrative. Headlines around Samsung and China's DeepSeek added further noise. Against that backdrop, Nvidia's flat close shows the market still prices it apart from the memory makers.
Short-term · 1–3 weeks
LongBullish
Maintaining the long and the bullish stance. Today's entire signal is relative strength: the memory chain was gutted, semis broadly struggled, the AI capex narrative faced its first systematic challenge — and it fell 0.10%. Entry at $208–216 above the 50-day at $205.85, stop at $198 structurally above the 200-day at $193.77, and a $250 target just beyond the $236.54 high. With a 3.6% ATR, that 9.6% stop distance absorbs more than two standard deviations of daily movement, so this can be sized as a normal allocation rather than a wager — a scarce property among today's names.
Entry $208~216Stop $198Target $250
Long-term · months+
Accumulate
A 74.1% gross margin and 70.7% revenue growth still hold at a $5.3T valuation, and 33.5x is not expensive for that pair. Sixty-four analysts converging on 43.5% upside reflects fundamental consensus rather than a crowded trade.
If hyperscaler returns on AI capex are disproven, demand contracts in step
Customer-designed ASICs such as Broadcom's erode general-purpose GPU share over time
Geopolitical and export-control variables on China revenue are hard to price
Signal BacktestCumulative +7.56%price itself +10.84%1/1 closed trades wonprofitable since 07-07
07-04Long$194.83 → closed $202.8107-18+4.10%
08-05Long$211.94 → open → $218.99+3.33%
Community Voices
WSB · Mentions fell from 226 to 153 for sixth place: the chatter receded while the price didn't move an inch. This shareholder base stopped consulting forums a long time agoOriginal ↗
Institutional Views
华尔街共识 · 64 analysts average a $314.29 target, roughly 43.5% above spot, at a 1.12 rating near strong buy
+8.20%07-09“The whole sector got dragged down by memory and it closed green at 0.55%. When the market starts doubting whether cloud AI spending pays back, custom silicon is the answer that saves them money”
Technicals — It closed at $420.56, up 0.55%, finishing green on a day semiconductors were broadly pressured — excellent relative strength. Price holds firmly above the 50-day ($394.92) and 200-day ($367.20) in a complete bullish stack. RSI(14) at 62.5 is healthy and RSI(7) at 75.0 runs warm. Weekly and monthly gains of 10.6% and 14.7% leave 17.7% of headroom to the $495.00 high. ATR of $17.09 implies a 4.1% daily range, mild for semis. The 50-day at $394.92 is the nearest structural support, reclaimed and confirmed just yesterday.
Fundamentals — Q2 FY26 AI semiconductor revenue of $10.8B grew 143%, with Q3 AI revenue guided to $16B at over 200% growth. Trailing revenue growth is 32.3% with EPS up 125.8% on a 65.7% gross margin at 70.0x earnings. Today's doubt about hyperscaler returns on AI capex is arguably a tailwind for Broadcom: the more cloud providers need to prove spending efficiency, the greater their incentive to substitute custom ASICs for general-purpose GPUs — and that substitution is exactly where Broadcom's revenue comes from.
News — Broadcom rose 0.55% on 8/6, standing out against a gutted memory chain and broadly pressured semiconductors. The core driver remains expanding custom ASIC partnerships with major cloud service providers, as tech giants seek tailored silicon for proprietary AI workloads and Broadcom's leadership keeps winning high-value contracts. Morgan Stanley had reiterated Overweight across both Broadcom and Nvidia. Notably, the day's doubts about returns on AI capex did not touch Broadcom, suggesting the market files custom silicon under cost reduction rather than spending.
Short-term · 1–3 weeks
LongBullish
Maintaining the long and the bullish stance. Today validated yesterday's read: the reclaim of the 50-day at $394.92 held, and it finished green on a day the sector struggled. Entry at $400–414 above the 50-day, stop at $383 structurally between the 50-day and the 200-day at $367.20, and a $470 target short of the $495 high. There is a second layer to the logic: today's doubt about returns on AI capex sharpens hyperscalers' incentive to cut costs with custom ASICs — the same doubt that is a risk for Nvidia is an order book for Broadcom.
Entry $400~414Stop $383Target $470
Long-term · months+
Accumulate
Custom ASIC is the only realistic path for hyperscalers to reduce general-purpose GPU dependence and demonstrate efficiency on AI spending. AI semiconductor growth of 143% and a 200%-plus Q3 guide show that substitution accelerating.
At 70.0x there is limited tolerance for deceleration
High customer concentration makes losing any single account material
Hyperscalers' in-house silicon teams erode custom pricing power over time
Signal BacktestCumulative +8.20%price itself +8.20%profitable since 07-10
07-09Long$388.69 → open → $420.56+8.20%
Community Voices
WSB · Still absent from the leaderboard: on the sector's loudest day it drew no discussion at all. Not many names on Broadcom's register got there via a forumOriginal ↗
Institutional Views
华尔街共识 · 55 analysts average a $529.43 target, roughly 25.9% above spot, at a 1.16 rating near strong buy
Long
8
PLTRPalantir Technologies Inc. · Packaged Software
Open PositionWatchlist
+21.92%07-02“DDOG, HUBS and APP each shed a fifth this week and it gave back just 1.58%, holding a 28.7% week. In this software bloodbath, the names that can prove their growth finally got separated from the ones that only narrate it”
Score8/10RSI(14) 66.41-week gain +28.7%P/E TTM 133.3Signal return +23.88%Consensus upside +26.8%
Technicals — It closed at $155.92, down 1.58%, a modest give-back on a day three heavyweight software names cratered together — DDOG -19.0%, HUBS -19.1%, APP -19.7% — making its relative strength conspicuous. Price holds above the 50-day ($131.81) and 200-day ($152.33), preserving the bullish stack built on the 8/4 gap. RSI(14) at 66.4 is firm without being overbought and RSI(7) at 72.7 is moderate. Weekly and monthly gains stand at 28.7% and 16.6%, with an ATR of $8.38 implying a 5.4% daily range. The $207.52 high is 33.1% above, while the 200-day at $152.33 is the key post-gap support and today's close held above it.
Fundamentals — Q2 revenue of $1.94B grew 93%, with US commercial up 149% and government up 90% at a 55.1% net margin, and full-year guidance was raised to $8.15–8.16B. At 133.3x trailing earnings it remains among the most expensive names here, but today's control group is instructive: DDOG trades at 611.9x with 29.5% growth and HUBS at 71.7x with 21.1% growth, and both were savaged for guidance that fell short. Against that comparison, Palantir's 78.9% revenue growth and 84.8% gross margin explain why it gave back only 1.58%.
News — Palantir slipped 1.58% on 8/6, a normal digestion after the 29.45% surge on 8/4. What deserves recording is the sector backdrop: Datadog fell 19.0% — its largest single-day drop on record — despite beating and raising full-year guidance; HubSpot fell 19.1%, also a record single-day decline, on soft guidance and net customer additions far below its internal target; and AppLovin fell 19.7% on a revenue miss and slowing core gaming. The common thread is decelerating growth, and Palantir's US commercial revenue grew 149% last quarter. That gap is why it wasn't swept up today.
Short-term · 1–3 weeks
LongLean bullish
Maintaining the long. Today was a quality check on this position: in the same expensive-software cohort, DDOG, HUBS and APP each fell roughly a fifth while Palantir gave back 1.58% and held the 200-day at $152.33. The difference is verifiable growth — 149% US commercial expansion is not a narrative. Entry at $148–155 near the 200-day, stop at $137 below the gap's midpoint, and a $196 target all carry over from 8/4, because neither the logic nor the key levels have changed. The 133.3x multiple remains the single largest risk, which is why this stays lean bullish rather than bullish.
Entry $148~155Stop $137Target $196
Long-term · months+
Neutral
Twin engines at 149% US commercial and 90% government growth prove enterprise AI spending has entered scaled integration, and a 55.1% net margin shows it isn't growth bought with cash burn. But 133.3x prices years of flawless execution in advance.
At 133.3x a single deceleration is unforgiven, and today's DDOG is the live case study
Heavy government exposure ties revenue to budget and political cycles
The entire software sector's valuation is being systematically reassessed
Signal BacktestCumulative +21.92%price itself +24.01%0/1 closed trades wonprofitable since 07-04
07-02Long$125.73 → closed $123.5307-29-1.75%
08-04Long$125.65 → open → $155.92+24.09%
Community Voices
WSB · It has dropped out of the top fifteen entirely — third place when it gained 29% on 8/4, unmentioned two days later. Attention arrives and leaves fast; what stayed behind this time is a 23.88% signal returnOriginal ↗
Institutional Views
华尔街共识 · 35 analysts average a $197.71 target, about 26.8% above spot, at a 1.44 buy rating — up again from $189.04 before the print
0.00%07-14“The first time since going public it missed its own guidance midpoints, with EPS a single cent from perfect. But the market never wanted perfect, it wanted acceleration. Nine words — model improvement slower than normal in core gaming — cost a fifth of the company”
Score6/10RSI(14) 28.9RSI(7) 21.3Q2 revenue $1.92B vs $1.94B est.vs 52w high -55.0%Consensus upside +70.3%
Technicals — It closed at $335.67, down 19.66%, within 1.0% of its 52-week low at $332.19, on relative volume of 2.11x confirming panic selling. Price sliced through the 50-day ($482.93) and 200-day ($516.19), leaving a thoroughly bearish stack. RSI(14) at 28.9 and RSI(7) at 21.3 are both deeply oversold. The stock is down 14.6% on the week, 37.9% on the month and 55.0% from its $745.61 high, with an ATR of $29.59 implying an 8.8% daily range. The $332.19 low sits 1.0% below as the only technical reference — but a stock making new lows has no support to speak of.
Fundamentals — Q2 adjusted EPS of $3.76 versus $3.75 expected was nearly perfect, while revenue of $1.92B grew 53% but fell short of the $1.94B estimate. Q3 revenue guidance of $2.06–2.09B carries a $2.07B midpoint just under the $2.08B consensus. The trailing figures are genuinely attractive: 20.0% revenue growth, 104.7% EPS growth, an 87.5% gross margin and a multiple of only 29.6x. The problem isn't the numbers but management's remarks on the call: the core gaming segment underperformed because model improvement ran slower than normal — and model improvement is what the company itself identifies as its key growth driver. Piper Sandler noted this was the first time since the IPO that it missed its own revenue and adjusted EBITDA guidance midpoints.
News — AppLovin plunged 19.66% on 8/6, among the largest declines by any mid-to-large-cap tech name that day. The print itself wasn't bad: EPS of $3.76 edged past the $3.75 estimate on 53% revenue growth. The damage came from two places — revenue of $1.92B missed the $1.94B estimate, and management conceded on the call that the core gaming segment underperformed because the model improvement driving growth ran slower than normal. Piper Sandler flagged that this was the first time since the IPO that AppLovin missed both its own revenue and adjusted EBITDA guidance midpoints. For a company whose valuation premium was built on always beating, breaking that streak is itself the event.
Short-term · 1–3 weeks
NeutralSidelines
No direction. A 29.6x multiple with an 87.5% gross margin, 104.7% EPS growth and 70.3% consensus upside makes this the day's most tempting apparent mispricing — but all three numbers are compromised. That upside rests on pre-earnings targets and cuts are only a matter of time; the deeply oversold reading came on a day the stock approached its 52-week low, which marks the start of a trend rather than its end; and management's admission that model improvement is running slower than normal points to the growth engine itself decelerating, not a one-off disturbance. Reassess once targets reset and the $332.19 low survives a test.
Entry Sidelines; wait for targets to reset and for $332.19 to holdStop —Target —
Long-term · months+
Neutral
An 87.5% gross margin and 104.7% EPS growth show the model's leverage remains powerful, and 29.6x isn't demanding for a growth name. But growth depends entirely on continuous improvement of the ad model, and management has just conceded that engine is slowing.
Slowing model improvement strikes at the growth engine itself, not a one-off
The first miss of its own guidance midpoints since the IPO breaks the premise of its valuation premium
Consensus targets don't yet reflect this print, leaving large downgrade risk
Community Voices
StockTwits · Absent from the trending board: a 20% drop and no crowd. This was never a retail name — these are institutions recalculating what a company that always beats is worth once it doesn'tOriginal ↗
Institutional Views
华尔街共识 · 36 analysts average a $571.72 target, a striking 70.3% above spot, at a 1.21 rating near strong buy — but these predate the print and bulk cuts are near-certain
Piper Sandler · Noted this was the company's first miss of its own revenue and adjusted EBITDA guidance midpoints since going publicSource ↗
New today“Beat, raised full-year guidance, still growing large enterprise accounts — and earned its largest down candle ever. At 611x, good enough is the verdict, and one soft sequential quarter repays three years of borrowed multiple”
Score6/10RSI(14) 39.0Q2 results EPS $0.65 vs $0.58; revenue $1.12B vs $1.08BFCF margin 29% → 25%P/E TTM 611.91-day drop -19.03% (record)
Technicals — It closed at $229.29, down 19.03%, the largest single-day decline in company history — surpassing the roughly 17.8% drop of March 2020 — on relative volume of 3.40x. Price sliced through the 50-day ($248.83) while holding 35.3% above the 200-day ($169.51). RSI(14) at 39.0 and RSI(7) at 29.2 have turned weak, but with RSI(14) still above 30 there is technical room below. The stock fell 13.1% on the week and 10.8% on the month, with an ATR of $16.34 implying a 7.1% daily range, and sits 21.7% under its $292.72 high. The nearest structural support is the $200 round number, then the 200-day at $169.51.
Fundamentals — Q2 EPS of $0.65 beat the $0.58 estimate and revenue of $1.12B beat $1.08B, while the company raised both full-year revenue and earnings guidance and kept growing high-value enterprise customers. Q3 guidance of $0.63–0.65 EPS on $1.135–1.145B revenue tops consensus of $0.61 and roughly $1.11B. This was a comprehensive beat-and-raise. Yet the market fixed on two things: free cash flow margin compressing from 29% to 25%, and a flattening sequential growth slope. A 611.9x trailing multiple against 29.5% revenue growth means any deceleration gets repaid in market capitalization.
News — Datadog fell 19.03% on 8/6, its largest single-day decline on record, despite a comprehensive beat and a raised full-year outlook, having traded down as much as 20% premarket. Three explanations circulated: free cash flow margin compressing from 29% to 25%; modest sequential growth guidance read as a possible slowdown in core observability demand; and reports that a leading AI customer flagged a weaker second-half outlook. Fundamentally this was a sell-the-fact reaction — a 611.9x valuation requires not a beat but an accelerating beat. Several analysts argued afterward that the selloff created a buying opportunity.
Short-term · 1–3 weeks
NeutralSidelines
No direction. The print was objectively good — a beat, a raise, growing enterprise accounts — and the selloff is a valuation problem rather than an operating one. That is precisely why I won't catch it today: repricing a 611.9x multiple doesn't finish in a session, RSI(14) at 39.0 hasn't reached oversold so there is technical room below, and the free cash flow compression from 29% to 25% needs another quarter to confirm or refute. Wait for RSI to genuinely reach oversold and for the $200 round number to produce a clear reaction; only then is the risk/reward measurable.
Entry Sidelines; wait for RSI to reach oversold and for $200 to produce a reactionStop —Target —
Long-term · months+
Neutral
Revenue growth of 29.5%, a 79.9% gross margin and steadily growing high-value enterprise accounts show the observability demand base is solid. But a 611.9x trailing multiple means the gap between valuation and fundamentals takes years of growth to close.
Free cash flow margin fell from 29% to 25%, a deteriorating return on spending
A leading AI customer reportedly flagged a weaker second-half outlook
At 611.9x, any deceleration is amplified into a crash
Community Voices
StockTwits · Absent from the trending board on a record decline. That means institutions repricing a 611x asset, not a sentiment tradeOriginal ↗
Institutional Views
华尔街共识 · 50 analysts average a $282.80 target, roughly 23.3% above spot, at a 1.23 rating near strong buy — though these predate the print
New today“An 8% EPS beat and a revenue beat, and it still lost a fifth over two or three thousand missing customers. A growth multiple never buys past profit, it buys the next cohort — and this cohort didn't show up”
Score5/10RSI(14) 44.3Q2 results EPS $3.26 vs $3.02; revenue $911.7MNet new customers 7,000 vs 9,000–10,000 targetvs 52w high -61.5%1-day drop -19.1% (record)
Technicals — It closed at $202.43, down 19.10%, the largest single-day decline in company history, on relative volume of 4.58x. Price broke the 50-day ($207.55) and sits 28.2% below the 200-day ($282.08) in a thoroughly bearish stack. RSI(14) at 44.3 and RSI(7) at 35.2 have weakened without reaching oversold. The stock fell 14.2% on the week yet remains up 1.2% on the month, indicating it had been basing at low levels. ATR of $20.09 implies a 9.9% daily range. It now sits 61.5% below the $525.51 high and only 19.3% above the $169.63 low.
Fundamentals — Q2 adjusted EPS of $3.26 beat the $3.02 estimate by 7.9% and revenue of $911.7M grew 19.8%, also topping the roughly $898M consensus. Trailing revenue growth is 21.1% on an 83.2% gross margin at 71.7x earnings. The damage sits in three forward data points: full-year revenue guidance was cut; Q3 revenue guidance of roughly $924.5M came in about 1.8% below consensus and implies deceleration to around 14% growth; and net new customers totaled just 7,000 for the quarter, reaching 306,446, well below the company's internal 9,000–10,000 target. Investor skepticism about the pace of AI monetization overwhelmed the quarter's beat.
News — HubSpot fell 19.10% on 8/6, its largest single-day decline on record, followed by multiple downgrades and target cuts. The print itself beat — EPS of $3.26 versus $3.02 and revenue of $911.7M versus roughly $898M — but three forward blows compounded: full-year revenue guidance was cut, Q3 guidance landed about 1.8% below consensus implying deceleration to roughly 14%, and net new customers of 7,000 fell far short of the internal 9,000–10,000 goal. Doubts about the pace of HubSpot's AI monetization were confirmed by this report. Some analysts framed it as a transition from growth stock to value stock — a transition that typically comes with a systematic reset lower in the valuation anchor.
Short-term · 1–3 weeks
NeutralSidelines
No direction. The distinction from DDOG must be stated: DDOG beat and was punished by its multiple, whereas HubSpot cut its own full-year outlook and badly missed its internal customer-add target — that is operating deceleration, not merely a valuation issue. Implied growth falling from 19.8% to roughly 14% is a genuine change in slope. RSI(14) at 44.3 isn't even near oversold, so the selling may be unfinished, and with several firms downgrading, the $240.18 target will keep drifting lower. Until there is evidence growth has stabilized, an 18.6% paper upside isn't worth the bet.
Entry Sidelines; wait for downgrades to finish and for evidence growth has stabilizedStop —Target —
Long-term · months+
Neutral
An 83.2% gross margin and a base above 300,000 customers show the product moat holds, and 71.7x would not be expensive if growth returned above 20%. But implied growth of 14% and customer adds below its own target suggest penetration of the SMB CRM market is topping out.
Net customer adds far below the internal target signal a decelerating growth engine
The market broadly doubts its AI monetization pace, with no verifiable data yet
Multiple firms are cutting ratings and targets; the reset is unfinished
Community Voices
StockTwits · Absent from the trending board on a record drop. SaaS valuation resets happen quietly — by the time retail notices, the anchor has already movedOriginal ↗
Institutional Views
华尔街共识 · 37 analysts average a $240.18 target, about 18.6% above spot, at a 1.55 rating leaning neutral — with several firms already downgrading and cutting targets after the close
New today“The first report as a standalone company came with a $300M guidance cut. Precision castings are scarce, every one goes to Boeing and Airbus OEM lines, and the high-margin aftermarket waits. This isn't a demand problem — it's being last in the queue”
Score5/10RSI(14) 32.3RSI(7) 20.2Q2 EPS $1.87 vs $2.12 est. (-32% YoY)FY guidance cut $300MOrganic growth guide 7–9% → 4–5%
Technicals — It closed at $156.47, down 23.16%, printing a fresh 52-week low of $150.03 intraday on relative volume of 7.54x — extreme panic selling. The name lacks 50-day and 200-day references given its short standalone history, leaving the $150.03–$297.50 52-week range as the only anchor, with price just 4.3% above the low. RSI(14) at 32.3 and RSI(7) at 20.2 are both deeply oversold. It fell 23.8% on the week and 34.2% on the month, with an ATR of $17.33 implying an 11.1% daily range. Without a moving-average structure, support can only be inferred from volume shelves, far less reliably than for a seasoned name.
Fundamentals — In its first quarter as a standalone company, revenue of $4.52B grew 5% while adjusted EPS collapsed 32% to $1.87, far below the $2.12 consensus, with roughly $100M attributable to separation costs and inventory obsolescence. Full-year guidance was cut by $300M and organic sales growth guidance slashed from 7–9% to 4–5%. The cause is a physical supply constraint: a precision casting shortage means scarce parts are routed first to Boeing and Airbus OEM lines, squeezing the higher-margin aftermarket business. No P/E or gross margin data is available for cross-checking.
News — Honeywell Aerospace fell as much as 24% intraday on 8/6, touching a post-listing low of $150.03 before closing down 23.16%. This was its first report as a standalone company and a textbook failed debut. The company cut full-year 2026 guidance by $300M, explaining that a precision casting shortage forces scarce parts toward Boeing and Airbus OEM lines rather than the higher-margin aftermarket. Adjusted EPS fell 32% year over year to $1.87, including roughly $100M of separation costs and inventory obsolescence charges, and organic sales growth guidance was cut from 7–9% to 4–5%.
Short-term · 1–3 weeks
NeutralSidelines
No direction. RSI(7) at 20.2 and 53.7% consensus upside look tempting, but three obstacles stand in the way. There is no 50-day or 200-day, so even a technical stop cannot be set reliably. That 53.7% comes from only 16 analysts using pre-cut targets. And the casting shortage is a physical supply constraint with no published resolution timeline — unlike a one-off write-down it cannot be modeled, and it will keep squeezing aftermarket revenue. Day one of a new listing low offers no support. Wait for evidence the constraint is easing.
Entry Sidelines; wait for evidence the casting supply constraint is easingStop —Target —
Long-term · months+
Avoid
Aftermarket should be aerospace's highest-quality cash flow stream, yet the casting shortage prevents the company from allocating parts to it. Until the supply constraint clears, the valuation flexibility promised by the spin-off cannot be realized.
The precision casting shortage has no published resolution timeline
Organic growth guidance was nearly halved, from 7–9% to 4–5%
Without moving averages or valuation benchmarks, risk cannot be measured conventionally
Community Voices
StockTwits · Absent from the trending board despite a 23% drop to new lows. A freshly spun-off name has no shareholder base, and therefore nobody to catch the knifeOriginal ↗
Institutional Views
华尔街共识 · 16 analysts average a $240.42 target, a striking 53.7% above spot, at a 1.69 rating leaning neutral — thin coverage and pre-cut data, so of limited use
Neutral
6
SPCXSpace Exploration Technologies Corp · Space & Communications
MomentumSocial BuzzWatchlist
+1.83%07-02“Two days ago everyone was waiting for the lockup to crush it; on the day itself it rose 6.14%. What defeats a supply shock is never the selling — it's everyone having already crowded onto the same side of the boat”
Score6/10RSI(14) 42.51-day gain +6.14%Q2 revenue $7.81B / +92%Q2 capex $184亿 / $18.4BLockup expiry 8/6, now passed
Technicals — It closed at $114.92, up 6.14%, on relative volume of 2.93x — a high-volume advance on lockup day, the opposite of what the market broadly expected. The name still lacks 50-day and 200-day references, leaving the $104.83–$225.64 52-week range as the only anchor, with price 9.6% above the low and 49.1% below the high. RSI(14) at 42.5 and RSI(7) at 46.2 are both neutral. The week is down just 0.2% while the month is down 27.7%. ATR of $11.10 implies a 9.7% daily range. Technical analysis here remains constrained by the absence of moving-average structure.
Fundamentals — Q2 revenue of $7.81B grew 92% and beat estimates, but quarterly capital expenditure of roughly $18.4B ran at 2.4x revenue. The company is now a three-segment enterprise spanning space, connectivity and AI following the February 2026 integration of xAI and X, at a market capitalization near $1.51T. There is still no P/E or gross margin available for cross-checking, making it the least financially transparent name in today's deep dives. The $227.09 consensus target implies 97.6% upside, the highest on the board — but that figure rests on an extremely thin base of verifiable financials.
News — August 6 was SpaceX's first major post-listing lockup expiration — the foreseeable supply shock I named explicitly in the two prior briefs. The outcome inverted the expectation: the stock rose 6.14% on relative volume of 2.93x. The maiden report after the close on 8/4 had knocked it as much as 8.8% postmarket on $18.4B of quarterly capex, but that damage was largely repaired within two sessions. Two things follow: the market had priced lockup selling fully, arguably excessively, in advance; and the 92% revenue growth narrative still finds buyers. The question of payback on that capex isn't resolved — merely deferred.
Short-term · 1–3 weeks
NeutralSidelines
Staying sidelined, but the part I got wrong needs stating plainly: in the two prior briefs I flagged the 8/6 lockup as a foreseeable supply shock, and the actual outcome was a 6.14% advance on heavy volume. That call was directionally wrong, because the market had already priced the selling in advance. The core reason for taking no direction, however, still holds unchanged: without a 50-day or 200-day, a stop cannot be set reliably; quarterly capex at 2.4x revenue leaves the payback period entirely unclear; and there is no P/E or gross margin to cross-check. A 97.6% consensus upside cannot be supported by verifiable financials. Wait for the moving-average structure to form.
Entry Sidelines; wait until a 50-day forms and a technical framework becomes possibleStop —Target —
Long-term · months+
Neutral
Revenue growth of 92% and a unique three-segment footprint across space, connectivity and AI make for an unmatched asset base, and the strength on lockup day shows the market will pay a premium for that narrative. But with quarterly capex at $18.4B, the valuation rests on story until free cash flow turns positive.
The payback period on $18.4B of quarterly capex is entirely unclear
Without P/E or gross margin data, the valuation cannot be cross-checked
Lockup selling didn't hit on day one, but the added float is a persistent supply
Signal BacktestCumulative +1.83%price itself -27.05%1/1 closed trades wonprofitable since 07-04
07-02Long$157.54 → closed $160.4207-07+1.83%
Community Voices
WSB · At 398 mentions for third place, easing from 450 but still near the top with 1,508 upvotes. Retail didn't run on lockup day — it stayed to watch, an unusual composure for the occasionOriginal ↗
Institutional Views
华尔街共识 · 38 analysts average a $227.09 target, a striking 97.6% above spot, at a 1.37 buy rating — the widest upside on the board, backed by the least verifiable financial data
-1.98%08-04“The Hang Seng fell 1.49% with tech taken to the woodshed, yet the WuXi complex printed a five-year high just yesterday. Southbound money sold HK$1.46B net on the day and spared exactly one chain: innovative drugs”
Technicals — It closed at HK$178.00, down 0.95%, falling less than the broad market on a day the Hang Seng dropped 1.49% and HS Tech 2.28% — solid relative strength. Price holds above the 50-day (HK$146.36) and 200-day (HK$122.24) in a complete bullish stack. RSI(14) eased from 76.3 to 68.9 and RSI(7) from 86.7 to 71.2, materially relieving overbought pressure — exactly the healthy digestion anticipated when yesterday's note warned that any good news landing could trigger profit-taking. The week is still up 13.3% and price sits just 5.2% below the HK$187.80 high. ATR is HK$7.92.
Fundamentals — First-half 2026 revenue of RMB28.90B grew 38.93% with net profit of RMB11.08B up 29.43%, crossing RMB10B for a half year for the first time, while full-year revenue guidance rose from RMB51.3–53.0B to RMB58.5–60.5B. The stock trades at 21.5x trailing earnings with EPS up 65.7%, revenue up 29.9% and a 52.6% gross margin. Consensus targets have climbed from HK$188.77 on 8/4 to HK$208.74 on 8/5 and now HK$213.85 — two raises in three days, showing analysts still catching up to the guidance revision. Huachuang Securities has noted that warming pharma investment and financing globally should transmit CRO front-end order growth into earnings.
News — Hong Kong weakened across the board on 8/6: the Hang Seng fell 1.49% to 25,530.28 and HS Tech 2.28%, with platforms broadly lower — Baidu -4%, Alibaba -2.89%, Tencent -2.64%, Xiaomi -2.82% — while southbound flows turned to net selling of HK$1.46B, the first flip from buying in recent sessions. Against that, WuXi AppTec fell only 0.95%. The prior session on 8/5 had seen its H-shares gain more than 11% and its A-shares hit limit-up at a five-year high, adding over RMB38B of market value in a day. TCM and innovative-drug names were among the few directions attracting money that day.
Short-term · 1–3 weeks
LongLean bullish
Maintaining the long. Today's signal is healthy: RSI(7) fell from 86.7 to 71.2, digesting the overbought condition while price gave up only 0.95% — far better than working it off through a selloff. Falling less than the index on a day the Hang Seng dropped 1.49% and southbound flipped to selling indicates a stable shareholder base. The entry guidance shifts from yesterday's do-not-add to an actual HK$168–176 pullback zone (the earlier HK$168–175 was never touched), the stop stays at HK$162, and the target rises to HK$213 following consensus up from HK$208. RSI at 68.9 is still elevated, which is why this stays lean bullish rather than bullish.
Entry HK$168~176Stop HK$162Target HK$213
Long-term · months+
Accumulate
A backlog up 25.2% provides two years of revenue visibility, Q2 growth accelerated to 47.71%, and full-year guidance was raised by more than RMB7B in one step. Warming global pharma financing is transmitting into orders, making this an industry cycle rather than a single-company story. At 21.5x against 65.7% EPS growth the valuation remains reasonable.
US biosecurity legislation is a permanent tail risk for the sector
Southbound flows flipped to selling, weakening the overall Hong Kong liquidity backdrop
Just 5.2% below its 52-week high, with little reference above beyond untested territory
Signal BacktestCumulative -1.98%price itself -1.98%profitable since 08-05
08-04LongHK$181.6 → open → HK$178-1.98%
Community Voices
港股通 · Southbound flipped to net selling of HK$1.46B, yet pharma was among the few directions that firmed. What money keeps while it is trimming says more than what it buys while addingOriginal ↗
Institutional Views
华尔街共识 · 18 analysts average a HK$213.85 target, about 20.1% above spot, at a 1.08 rating near strong buy — raised successively from HK$188.77 over three days
+25.37%07-02“Three days ago southbound money ranked it first in turnover; today it sold HK$1.46B net and walked. The Qwen3.8 story didn't change, Hong Kong's wallet did. After a 29.3% month, a give-back is the bill, not the turn”
Score7/10RSI(14) 63.8HK session -2.89%P/E TTM 20.81-month gain +29.3%Consensus upside +47.5%
Technicals — It closed at HK$125.40, up 0.80% on this cross-timezone snapshot basis, while the local Hong Kong session on 8/6 fell 2.89%. Price holds above the 50-day (HK$111.45) but remains 8.8% below the 200-day (HK$137.56) — still the key unreclaimed gate, and a wider gap than the 7.5% of the prior two sessions. RSI(14) eased from 68.9 to 63.8 and RSI(7) from 79.6 to 67.8, relieving overbought pressure. The week is up 9.9% and the month 29.3%, a 41.5% recovery from the HK$88.65 low. ATR is HK$4.88.
Fundamentals — It trades at 20.8x trailing earnings with EPS down 16.7%, revenue growth of just 4.6% and a 39.3% gross margin — the reported fundamentals remain unremarkable, and this rally is priced off an AI asset rerating rather than the current income statement. The Qwen3.8 model released on 8/3 carries 2.4 trillion parameters and ranks second only to Anthropic's Claude series on the third-party Arena leaderboard. The HK$184.97 consensus target implies 47.5% upside, the highest among today's Hong Kong names and wider than yesterday's 45.0% as the price pulled back.
News — Hong Kong platform stocks weakened across the board on 8/6, with Alibaba down 2.89% in the local session alongside Baidu off more than 4%, Tencent -2.64%, JD -2.08% and Xiaomi -2.82%, as the HS Tech index fell 2.28% to 4,820.78. The notable shift was in flows: southbound turned to net selling of HK$1.46B, a sharp reversal from 8/4 when Alibaba led turnover on both the Shanghai and Shenzhen channels. The names that firmed were pure AI model plays — MiniMax up more than 17% and Zhipu up 4% — so money didn't leave the AI theme, it rotated from large platforms into model-native names.
Short-term · 1–3 weeks
LongLean bullish
Maintaining the long but stepping down from bullish to lean bullish — on flows rather than fundamentals. Southbound flipped to net selling of HK$1.46B and money visibly rotated from large platforms into pure model names like MiniMax and Zhipu, meaning the rerating momentum from Qwen3.8 is being diluted within Hong Kong itself. The 200-day at HK$137.56 remains unreclaimed and the gap widened from 7.5% to 8.8%, which is the wrong direction. Entry at HK$118–124 and the stop at HK$112 below the 50-day hold, while the target trims from HK$140 to HK$137 to align with the 200-day. A 20.8x multiple and 47.5% consensus upside still justify holding, but adding waits for southbound flows to return.
Entry HK$118~124Stop HK$112Target HK$137
Long-term · months+
Accumulate
The closed loop of owned cloud, self-trained models and commerce monetization is unique in China, and Qwen3.8's Arena ranking gives it a verifiable technical foundation. At 20.8x with 47.5% consensus upside, room for valuation repair remains.
Southbound flows flipped to selling and rotated visibly toward pure model names
Trailing EPS is down 16.7%; the AI narrative has not reached earnings
The 200-day remains unreclaimed with the gap widening, leaving the intermediate trend unconfirmed
Signal BacktestCumulative +25.37%price itself +33.26%0/1 closed trades wonprofitable since 07-09
07-02LongHK$94.5 → closed HK$94.107-04-0.42%
07-08LongHK$99.6 → open → HK$125.4+25.90%
Community Voices
港股通 · Topped southbound turnover on both channels three days ago; today the whole market saw HK$1.46B of net selling. Same money, two faces. It rotated into MiniMax and Zhipu, which says it wants pure model exposure, not a model carrying an e-commerce business on its backOriginal ↗
Institutional Views
华尔街共识 · 33 analysts average a HK$184.97 target, roughly 47.5% above spot, at a 1.17 rating near strong buy
+11.39%07-02“17.2x earnings, 53 analysts pointing to 44% upside, and it still took a 2.64% beating with the rest of the platforms. Cheap was never a talisman — but it is the only thing that lets you sleep through the drawdown”
Technicals — It closed flat at HK$479.20 on this cross-timezone snapshot basis, while the local Hong Kong session on 8/6 fell 2.64%. Price holds above the 50-day (HK$454.16) but sits 11.7% below the 200-day (HK$535.36), a gap that widened noticeably from 8.9% two sessions ago. RSI(14) eased from 60.7 to 55.8 and RSI(7) from 68.5 to 56.3, returning to neutral — amid today's field of extreme overbought and deeply oversold readings, Tencent's position remains among the least worrying. The week is up 2.0% and the month 3.9%, with an ATR of HK$15.48 and the 50-day at HK$454.16 as the nearest structural support.
Fundamentals — It trades at 17.2x trailing earnings with EPS up 21.3%, revenue up 15.0% and a 54.8% gross margin, putting the PEG well below 1 — the best growth-to-valuation match in today's field. Fifty-three analysts average a HK$690.65 target implying 44.1% upside at a 1.14 rating, an unusually tight consensus, with the gap wider than yesterday's 41.2% after the price eased. Tencent's central tension is unchanged: the fundamentals are beyond reproach but there is no catalyst to force a rerating — and today's rotation into pure model names like MiniMax and Zhipu bypassed it once again.
News — Tencent fell 2.64% in the local Hong Kong session on 8/6, tracking the HS Tech index down 2.28% alongside the broader platform complex. Baidu fell more than 4%, Alibaba 2.89%, JD 2.08% and Xiaomi 2.82%, while southbound flows turned to net selling of HK$1.46B. The names that rose were AI model plays — MiniMax up more than 17% and Zhipu up 4% — plus defensive corners such as coal and traditional Chinese medicine. Tencent had no standalone negative and simply traded as sector beta, but for a second consecutive session money chose to route around it toward pure model names, confirming it still isn't in the front rank of AI-theme allocation.
Short-term · 1–3 weeks
LongLean bullish
Maintaining the long. Today was sector beta rather than a company-specific negative, and RSI easing from 60.7 to 55.8 actually leaves the position more comfortable — amid a field of readings below 20 and above 70, Tencent is one of the few names whose risk can still be measured conventionally. The entry zone moves down from HK$468–480 to HK$460–472 near the 50-day at HK$454.16, with the stop held at HK$448 and the target at HK$535 below the 200-day. The weakness must be acknowledged: the gap to the 200-day widened from 8.9% to 11.7%, and for two straight sessions money has routed around it into pure model names, leaving the rerating catalyst still absent.
Entry HK$460~472Stop HK$448Target HK$535
Long-term · months+
Accumulate
A 17.2x multiple against 21.3% EPS growth and 15% revenue growth puts the PEG well under 1, WeChat's cash-flow stability is unmatched among Chinese platforms, and 53 analysts converging on 44.1% upside makes the discount consensus rather than controversy.
Without a standalone AI narrative, money keeps routing around it into pure model names
Game approvals and regulation remain policy variables that cannot be fully priced
The gap to the 200-day widened to 11.7%, slowing the intermediate trend repair
Signal BacktestCumulative +11.39%price itself +11.13%profitable since 07-04
07-02LongHK$430.2 → open → HK$479.2+11.39%
Community Voices
港股通 · Southbound sold HK$1.46B net, and money would rather chase MiniMax up 17% than touch Tencent at 17x. The market pays a premium for imagination and a discount for certainty; that ledger eventually reversesOriginal ↗
Institutional Views
华尔街共识 · 53 analysts average a HK$690.65 target, about 44.1% above spot, at a 1.14 rating near strong buy — wider than yesterday's 41.2%
Down 1.11% as 3x leverage amplified the Nasdaq's 0.1% slip, with RSI neutral at 52.7 pinned at the 50-day of $74.50. The week is still up 17.8%, but decay bites fast once index momentum fades — a day-trading tool, not an overnight hold.(not for long-term holding)
Essentially flat at +0.20% with RSI neutral at 44.8; up 23.2% on the week yet still down 20.0% on the month. That the memory bloodbath didn't sink it shows clear dispersion within semis — leveraged risk remains extreme.(not for long-term holding)
Down 0.53% as 3x the S&P's 0.2% decline, with RSI still firm at 62.7 after a 13.4% week. With the index easing from record highs, decay costs peak here — strictly a short-term tool.(not for long-term holding)
Down 0.56% alongside UPRO with RSI at 62.6, just 1.9% below the $300.96 high. As a record run takes its first breather, a leverage amplifier cuts both ways — strictly short-term.(not for long-term holding)
Up 1.07% as the 3x mirror of the Nasdaq's small decline, with RSI at 43.9 while the week is still down 16.8%. Even on a down day for the index its weekly return stays negative — inverse leverage is punishing to hold in a choppy tape.(not for long-term holding)
Down 0.16% with RSI still firm at 63.7, just 1.1% below the $776.85 high; the S&P ended its record streak with only a mild decline, leaving the trend structure intact.(Long-term: The core S&P 500 vehicle, above every moving average and a first choice for a long-term base position.)
Down 0.17% alongside SPY with RSI at 63.6, just 0.7% below the $714.16 high; the fee advantage compounds meaningfully over long holds.(Long-term: A low-cost S&P 500 vehicle and a default choice for long-term systematic investing.)
Down 0.37% to 714.65 with RSI at 54.3, sitting exactly on the 50-day at 714.70. Yesterday's confirmed breakout returned to the gate in a single session, and the reaction here decides near-term direction.(Long-term: The core Nasdaq 100 vehicle, with concentrated tech weighting and higher volatility than the S&P.)
Essentially flat at +0.01% with RSI at 60.1 on 1.52x volume; rising Treasury yields should pressure gold, yet it held the 50-day at 382.54, indicating safe-haven demand rising in parallel.(Long-term: A physical gold vehicle, inversely correlated to real rates, serving as a geopolitical and inflation hedge.)
Up 0.29% against the tape with RSI firm at 63.4 after an 11.4% week; miners' operating leverage amplifies gold's move as safe-haven demand returns, holding above the 50-day at 78.35.(Long-term: A gold-miner vehicle carrying operating leverage over physical gold, with correspondingly higher volatility.)
Up 0.03% with RSI at 60.2, tracking GLD at a lower expense ratio; the long-term holding vehicle for a safe-haven allocation.(Long-term: A low-cost physical gold vehicle suited to a long-term defensive allocation.)
Down 0.64% with RSI at 32.5 and RSI(7) deeply oversold at 18.1, below both the 50-day at 44.89 and 200-day at 44.82; utilities bleed systematically as yields rise, exactly matching the single-name action in SRE, EIX, PEG and LNT.(Long-term: A utilities vehicle, rate-sensitive and worth allocating to mainly in a falling-yield cycle.)
Down 0.32% with RSI at 58.6, just 1.5% below the $73.23 high; developed markets ex-US fell less than the US on an ebbing day, demonstrating diversification value.(Long-term: A developed-markets ex-US vehicle used to reduce single-market concentration.)
Down 0.16% with RSI at 61.8, just 1.3% below the $162.00 high; a single global equity basket that fell less than the Nasdaq — the least demanding diversification tool available.(Long-term: A total world equity vehicle covering global market capitalization in one line, suitable as a long-term core holding.)
Down 0.29% with RSI weak at 40.6, below the 50-day at 72.92 and 200-day at 73.79; rising Treasury yields pressed bond prices directly — the footnote to today's simultaneous decline in stocks and bonds.(Long-term: An aggregate bond vehicle used for portfolio duration and equity-bond balance.)
Down 1.29% and pinned right at the 50-day of $357.20 with RSI back to neutral at 52.4; at 18.0x against 112% EPS growth it remains the cheapest of the giants. Maintaining the long.
Essentially flat at -0.14% with RSI firm at 63.2, a 16.7% week intact and price just 5.2% below the $287.20 high; the AWS demand story was untouched by today's turbulence. Maintaining the long.
Down 5.07% on doubts over returns from AI capex, though the week is still up 24.9% with RSI neutral at 51.7. It failed to clear the 50-day at $92.40 and 200-day at $93.83. Maintaining the long, but watching closely.
Down 3.43% in give-back with RSI firm-neutral at 55.5, still above the 50-day at $145.46 after a 7.8% week; the liquid-biopsy demand trend is unchanged. Maintaining the long.
Down 3.33% in sympathy with HONA's casting shortage on the same supply chain, though RSI stays healthy at 58.0 after an 8.0% week and the $715B backlog is unchanged. Maintaining the long.
Essentially flat at -0.06% with RSI at 59.3; a more volatile market naturally favors a volume-driven business, and the $185.64 consensus target implies 24.0% upside. Maintaining the long.
Up 0.42% into fresh 52-week-high territory against a weak tape, but RSI at 76.4 is deeply overbought with consensus upside of just 6.1%. Holding, not adding.
Down 1.95% in give-back from highs with RSI overbought at 69.4, though a 9.9x multiple against 66% EPS growth still supports it after a 23.2% month. Maintaining the long.
Down 0.66% with RSI healthy at 59.8 and price just 2.9% below the $244.87 high; defensive pharma-distribution cash flow cushioned a turbulent day. Maintaining the long.
Down 1.29% through the structural support near the 50-day at $99.00 with RSI(7) weakening to 41.2, and it sits in the same aerospace supply chain as HONA and BA where the casting-shortage spillover isn't priced. Closing the position until that variable clears.
Up 1.07% to a fresh 52-week high against a weak tape, with RSI overbought at 75.1 and consensus targets now 2.0% below spot. It was ballast on the first day risk appetite ebbed. Holding, not adding.
Up 2.22% against the tape with RSI firm at 69.4 after gains of 16.7% for the week and 20.0% for the month, holding above the 50-day at $118.35 and 200-day at $132.70. Closing green on a day software cratered. Maintaining the long.
Down 7.01% in a sharp give-back; RSI is 57.0 but a 77.4x multiple against EPS down 17.0% and revenue down 2.0% cannot support the valuation. Closing the position.
Up 0.28% though the week is down 2.5%, with RSI back to neutral at 51.8 and price slipping out of the strong zone above the 50-day at HK$86.46. The HK$125.23 consensus target implies 39.0% upside. Maintaining the long, but momentum has softened.
Essentially flat at +0.11% with RSI at 65.7 holding above the 200-day at HK$88.91 after an 18.6% month; the easing-competition thesis is unchanged. Maintaining the long.
Essentially flat at -0.11% with RSI firm at 66.0 after a 19.0% month; at 14.2x against 72.2% EPS growth and a HK$50.50 target implying 43.2% upside, gold is a natural hedge as risk aversion returns. Maintaining the long.
Essentially flat at -0.05% with RSI at 66.7 above the 200-day at HK$35.20 after an 8.8% week, part of the same innovative-drug chain that firmed against the tape. Maintaining the long.
Essentially flat at -0.09% with RSI at 63.4 and price just 2.4% below the HK$240.00 high; at 14.4x, a bank benefits from rising yields. Maintaining the long.
Up 2.16% against the tape with a 22.2% week and RSI neutral at 49.4; the HK$533.42 consensus implies 126% upside though only seven analysts cover it, limiting its weight. PCB demand is resonating with AI hardware. Maintaining the long.
Up 0.77% but still 36% below the 50-day at HK$184.85 after a 27.2% month, with RSI weak at 41.4. The fiber demand narrative diverges sharply from the price and only eight analysts cover it. Closing the position pending trend confirmation.
Up 0.69% but still down 51.7% on the month and 41% below the 50-day at HK$60.02, with RSI weak at 37.6. The laminate cycle hasn't bottomed and yesterday's entry rationale is too thin. Closing the position.
Up 1.50% but still below the 50-day at $514.33 with RSI neutral at 47.8, as WSB mentions collapsed from 1,137 to 71, down 94%. Post-earnings attention drained without the position improving; staying sidelined.
Up 2.54% against the tape to $499.86, but RSI at 78.1 and RSI(7) at 86.1 are deeply overbought with consensus upside of just 12.3%. Closed out yesterday; staying sidelined pending a pullback.
Down 2.91% off the $305.00 high with RSI easing to neutral at 58.7; the $267.69 consensus target still sits 5.9% below spot and the valuation remains undigested after the 8/6 print. Staying sidelined.
Down 13.29% on doubts over AI capex returns and pressure across neoclouds, with RSI neutral at 46.2 yet still 15% below the 50-day at $223.94; volatility ahead of the 8/12 print is extreme. Sidelines.
Down 13.30% through both the 50-day at $359.53 and 200-day at $328.71 with RSI weakening to 44.1; AI server manufacturing took the brunt of capex doubts and the 52.0% consensus upside awaits revision. Sidelines.
Up 15.05% on Q2 revenue of $546M versus $515M expected and adjusted EPS of $0.28 against a $0.09 loss estimate, with Q3 guidance also above consensus — but RSI at 78.7 is deeply overbought and consensus targets sit 7.6% below spot. Sidelines.
Up 33.86% on positive 12-month TPIP extension data, BRINSUPRI revenue of $309.2M up 49% sequentially, and peak sales guidance above $14B — but RSI(7) at 87.1 is extremely overbought and chasing has inverted risk/reward. Sidelines.
Up 2.89% against the tape with RSI overbought at 69.8, above the 50-day at $178.48 and 200-day at $189.80 — but 112x against 6.0% EPS growth leaves the valuation unsupported. Sidelines.
Up 7.31% into fresh 52-week-high territory with RSI overbought at 73.7 on 2.1x volume — but the $1,074.23 consensus target sits just 0.4% above spot, leaving the breakout no valuation room. Sidelines.
Down 4.81% on 3.09x volume with RSI neutral at 51.2 but price below the 200-day at $1,888.79 and 28% off its high; no clear catalyst in Latin American e-commerce today. Sidelines.
Down 6.80% on 5.18x volume with WSB mentions exploding from 1 to 73; at 19.9x it looks cheap, but it sits 69% below its high and under all three moving averages with the adtech reset unfinished. Sidelines.
Up 10.11% and 22.9% for the week with RSI at 59.4 reclaiming the 50-day at $6.87, yet still 23% below the 200-day at $9.25 and 68% off its high, with no earnings anchor in voice AI. Sidelines.
Down 3.38% though the week is still up 49.0%, with RSI neutral at 52.8; the optics theme cooled amid AI capex doubts and price remains below the 50-day at $139.11. Sidelines.
Up 43.09% to a $6.39 52-week high on 5.65x volume after a 46.1% month with RSI at 69.8; cell therapy commercialization isn't yet profitable and the move has no valuation anchor. Sidelines.
Up 29.49% on 7.13x volume as WSB mentions exploded a hundredfold from 14 to 1,396, taking the top spot site-wide — yet price is still 36% below the 50-day at $3.18 and 75% off its high. Pure sentiment; sidelines.
Down 4.25% with RSI(14) at 21.1 and RSI(7) at 9.2 — the most extreme oversold readings on the board — after weekly and monthly declines of 24.6% and 24.4%, below every moving average. The decline hasn't halted; sidelines.
Down 0.41% with RSI(7) extremely oversold at 19.7 after declines of 27.1% for the week and 37.2% for the month, 75% below its high. The downtrend is intact and catching this is high-risk; sidelines.
Down 0.37% with RSI(7) deeply oversold at 15.6, below every moving average and just 6.8% above its 52-week low; utilities keep bleeding as yields rise. Sidelines.
Down 1.60% with RSI(7) extremely oversold at 13.7 after a 14.4% week, below the 50-day at $74.10 and 200-day at $67.33; the risk premium on California utilities isn't fully priced. Sidelines.
Down 0.46% with RSI(7) deeply oversold at 16.4, below the 50-day at $55.27 while hugging the 200-day at $51.80; the defensive appeal of pipeline assets weakens as yields rise. Sidelines.
Down 0.66% with RSI(7) deeply oversold at 15.7, below every moving average and just 1.1% above its 52-week low, as utilities bleed systematically. Sidelines.
Down 0.97% with RSI(7) oversold at 20.8, below every moving average after a 10.1% month, part of the same bleeding utilities cohort as SRE, EIX and PEG. Sidelines.
Down 1.97% with RSI at 24.0 among the lowest on the board, just 1.3% above its 52-week low and below every moving average, as defensives are systematically abandoned. Sidelines.
Down 2.49% with RSI oversold at 31.7 after a 23.0% month, just 5.9% above its 52-week low; HVAC demand tracks a soft residential market with no inflection. Sidelines.
Down 3.10% with RSI(7) deeply oversold at 16.8 after a 19.1% week, closing on the $92.28 low; auction-platform demand is softening with no stabilization signal. Sidelines.
Down another 2.77% with RSI oversold at 28.7 after a 17.7% week, below every moving average; two straight down sessions with no sign of a bottom. Sidelines.
Down 3.22% with RSI(7) deeply oversold at 14.7, slipping between the 50-day at $122.92 and 200-day at $109.11; REITs are pressured as yields rise. Sidelines.
Up 22.62% to a $128.01 52-week high on 4.41x volume with RSI(7) extremely overbought at 87.3 — but the $97.50 consensus target sits 21.8% below spot, leaving no room to chase. Sidelines.
Up 12.55% toward the $127.99 high with RSI overbought at 74.0 on 2.66x volume; at 20.3x against 20.1% EPS growth the fundamentals are sound, but chasing on breakout day isn't rational. Sidelines.
Up 17.32% toward the $24.58 high on 3.09x volume with RSI overbought at 70.5 after a 20.4% month; the background-screening breakout lacks proof of durability. Sidelines.
Up 6.45% toward the $110.08 high with RSI at 68.4 on 1.92x volume; food distribution's defensive profile found favor on a turbulent day, but valuation room is lacking. Sidelines.
Down 0.16% near the $213.26 high with RSI at 64.9 after an 11.7% month; restaurant defensiveness found favor but there was no catalyst today. Sidelines.
Down 50.48% — halved on 14.79x volume — with RSI(7) extremely oversold at 12.7 after declines of 48.0% for the week and 54.7% for the month. Day one of a collapse offers no support; sidelines.
Down 34.22% on 8.55x volume with RSI oversold at 28.3 after declines of 32.7% for the week and 44.9% for the month; vocational-education demand collapsed with no stabilization. Sidelines.
Down 18.55% on 6.77x volume with RSI(7) extremely oversold at 12.6, closing on the $28.90 low; specialty pharma demand is weakening with no sign of a bottom. Sidelines.
Up 22.49% to a $15.62 52-week high on 7.33x volume with RSI(7) extremely overbought at 81.0 after a 16.1% month; a small-cap device name with no verifiable anchor. Sidelines.
Up 37.52% on 13.28x volume and 62.1% for the week with RSI(7) extremely overbought at 83.2; the aerogel demand narrative has no earnings backing. Sidelines.
Up 40.78% on the board's highest relative volume at 17.32x, near the $5.84 high with RSI extremely overbought at 83.0 after a 44.9% week; a sentiment-driven low-priced name. Sidelines.
Down 5.25% with RSI weak at 41.1 after a 16.1% month, still below the 50-day at $12.94 and 200-day at $11.60; bitcoin miners are pressured as risk appetite ebbs. Sidelines.
Down 1.49% though the week is up 21.5%, with RSI neutral at 50.9; the quantum-computing concept remains below the 50-day at $18.68 and 200-day at $21.27, 72% off its high. Sidelines.
Down 2.78% with the software pullback, RSI still firm at 63.0 after a 23.6% month above the 200-day at $108.09 — but with DDOG and HUBS cratering, this isn't the environment to chase. Sidelines.
Down 4.48% on 7.7x volume with RSI weakening to 44.3, 73% below its high and 37% under the 200-day at $32.58; the valuation reset for the physician network isn't finished. Sidelines.
Up 1.88% but with RSI weak at 35.9 after a 16.0% month, still below the 50-day at $25.33 and 200-day at $27.39; both demand and regulation remain uncertain. Sidelines.
Up 8.71% capping an extraordinary 145.0% week, with RSI at 62.4 above the 50-day at $9.81 and 200-day at $7.97; a clinical-stage biotech with no earnings anchor after such a move. Sidelines.
Up 0.12% though the week is up 23.0%, with RSI neutral at 50.5 and price below the 50-day at $10.05 and 200-day at $11.02; the drone concept lacks a revenue anchor. Sidelines.
Down 3.77% with RSI weak at 38.2 after declines of 13.0% for the week and 28.2% for the month, below every moving average; the fast-casual expansion model is under pressure. Sidelines.
